Caiyun Ma

Dr. Caiyun Ma


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2025 in Experimental Cell Research
Verified
Journal Article
Open access
YZYongna Zhu
Yongna Zhu
XGXiang Ge
Xiang Ge
ZCZhi Chen
Zhi Chen
TCTingting Chen
Tingting Chen
YWYue Wu
Yue Wu
CMCaiyun Ma
Caiyun Ma
Stem cells from the apical papilla (SCAPs) show strong odontogenic ability and can form root dentin. However, the underlying mechanisms that control the odontogenic differentiation of SCAPs in an inflammatory environment need further exploration. In the present study, we explored the regulatory role of METTL3 in the differentiation of SCAPs originating from tooth with apical periodontitis. Stem cells from the apical papilla derived from healthy teeth (SCAPs) and teeth with apical periodontitis (AP-SCAPs) were successfully isolated and cultured. The expressions of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) were higher in AP-SCAPs. A decrease in METTL3 expression accompanied the decreased osteo-/odontogenic differentiation ability of AP-SCAPs. Exploring the role of METTL3 on the osteo-/odontogenic differentiation of AP-SCAPs revealed that overexpression of METTL3 upregulated the odontogenic ability of AP-SCAPs. However, silencing METTL3 exerted the opposite effect. Overexpression of METTL3 suppressed the expression of TNF-α and IL-6 in AP-SCAPs, whereas knockdown of METTL3 in these cells enhanced TNF-α and IL-6 expression. METTL3 regulates the osteo-/odontogenic differentiation of SCAPs and modulates their inflammatory response. Furthermore, overexpression of METTL3 upregulated the methylation level, mRNA, and protein expression of nuclear factor-IC (NFIC) during mineralization induction. NFIC silencing attenuated osteo-/odontogenic differentiation of METTL3-overexpressed AP-SCAPs. In conclusion, METTL3-mediated-m6A upregulated the odontogenic differentiation of AP-SCAPs via NFIC. This paper elucidates a novel mechanism regulating the odontogenic differentiation of AP-SCAPs, and METTL3 may be a new target for regenerative endodontic treatment.

12 August 2025 in Brain and Behavior
Verified
Journal Article
Open access
ZXZou Xiaoyun
Zou Xiaoyun
YWYe Wenhao
Ye Wenhao
WHWu Huan
Wu Huan
YYYang Yuanyuan
Yang Yuanyuan
LCLiu Changqing
Liu Changqing
CMCaiyun Ma
Caiyun Ma
Background: Glioma represent one of the most prevalent and lethal malignancies within the central nervous system. Recent studies have identified ITPRIPL1, a newly reported CD3ε‐inhibitory ligand, as a suppressor of T cell activation, thereby facilitating tumor immune evasion and offering a novel avenue for immunotherapeutic intervention in glioma.Methods: A comprehensive analysis was performed using datasets from The Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), and Gene Expression Omnibus (GEO). This included evaluating ITPRIPL1 expression levels in glioma, its association with clinicopathological features, prognostic significance, immune landscape, targeted drug sensitivity, and underlying biological functions. Ninety‐eight machine learning algorithm combinations were screened to identify the optimal predictive model. A nomogram was subsequently constructed and validated to assess the integrated prognostic impact of ITPRIPL1 expression on glioma patients.Results: Elevated ITPRIPL1 expression was positively correlated with higher tumor grade and poorer clinical outcomes. Immune infiltration profiling revealed that ITPRIPL1 expression was negatively associated with effector memory CD4⁺ T cells and type 17 T helper cells (Th17), but positively correlated with M2‐polarized macrophages and several immune checkpoint molecules. Moreover, drug sensitivity analyses and molecular docking studies highlighted a potential therapeutic relationship between ITPRIPL1 and antitumor agents such as AZD8055. The SuperPC model emerged as the most robust predictor and was utilized to develop a prognostic nomogram capable of reliably forecasting survival in glioma patients.Conclusions: This study reveals that ITPRIPL1 plays a dual role in glioma: It suppresses T cell–mediated immune responses, contributing to an immunosuppressive microenvironment, and interferes with the efficacy of antitumor drugs, thereby promoting tumor progression and ultimately leading to poor patient prognosis.

19 January 2026 in Brain and Behavior
Verified
Journal Article
Open access
YWYe Wenhao
Ye Wenhao
WHWu Huan
Wu Huan
ZXZou Xiaoyun
Zou Xiaoyun
YYYang Yuanyuan
Yang Yuanyuan
BJBi Junlei
Bi Junlei
CMCaiyun Ma
Caiyun Ma
Background: NSUN5 is a conserved RNA methyltransferase whose oncogenic role has been demonstrated in various cancers. However, its function and prognostic value in gliomas remain unclear. Methods: In this study, we systematically analyzed the expression and functional associations of NSUN5 in glioma using data from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases. A total of 117 machine learning algorithm combinations were employed to construct and validate a prognostic model for glioma patients. In addition, in vitro experiments were performed to further validate the expression and biological functions of NSUN5. Results: NSUN5 expression is significantly upregulated in glioma and is positively associated with tumor malignancy and poor prognosis. Immune infiltration analysis revealed a marked increase in M2 macrophages in the NSUN5 high‐expression group, and NSUN5 levels were positively correlated with the expression of multiple inhibitory immune checkpoints. In addition, drug sensitivity analysis and molecular docking suggested that NSUN5 may influence the response to Olaparib. Finally, based on NSUN5‐associated genes, we constructed 117 machine learning models and identified the optimal prognostic model, STRICOM, which demonstrated robust predictive performance for patient survival. Conclusion: High NSUN5 expression is closely associated with poor prognosis in glioma patients, highlighting its potential as a prognostic biomarker and therapeutic target.

22 July 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
XGXiang Ge
Xiang Ge
YZYongna Zhu
Yongna Zhu
YJYongting Ji
Yongting Ji
LJLina Jiang
Lina Jiang
XYXiu Ying
Xiu Ying
QYQingling Yang
Qingling Yang